alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 32****Certifications Pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350)**     The undersigned, as the President and Chief Executive Officer, and Executive Vice Presidentand Chief Financial Officer of Exide Technologies, each certify that     (1) the accompanying Quarterly Report on Form 10-Q for the period ended December 31, 2006,fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the SecuritiesExchange Act of 1934, as amended; and     (2) the information contained in the periodic report fairly presents, in all materialrespects, the financial condition and results of operations of Exide Technologies at the dates andfor the periods indicated.     A signed original of this written statement required by Section 906 has been provided to ExideTechnologies and will be retained by Exide Technologies and furnished to the Securities andExchange Commission or its staff upon request.     The undersigned expressly disclaims any obligation to update the foregoing certificationexcept as required by law.Date: February 7, 2007     /S/ Gordon A. Ulsh        Gordon A. Ulsh  President and Chief Executive Officer     /S/ Francis M. Corby, Jr.        Francis M. Corby, Jr.  Executive Vice President and  Chief Financial Officer
U. S. Department of Homeland Security

 Office for Domestic Preparedness

 Washington, D.C. 20531

ODP Information Bulletin

No. 92 January 2, 2004

TO: All State Administrative Agency Heads

All State Administrative Agency Points of Contact

FROM: C. Suzanne Mencer

Director

SUBJECT: State Homeland Security Strategy Deadline Extension

ODP has received additional feedback during recent weeks from participants in the State

Homeland Security Assessment and Strategy (SHSAS) program about the Online Data

Collection Tool (DCT). ODP has been working diligently to address these issues and to improve

the tool’s reliability and performance. We are aware that ongoing problems with the DCT have

made meeting deadlines challenging. We sincerely appreciate the patience and dedication that

users have shown in attempting to complete the SHSAS processes in accordance with the tight

schedule set forth in program guidelines.

Guidance provided in the SHSAS Program State Handbook required that all state strategies were

to be completed and submitted to ODP no later than December 31, 2003. Due to the ongoing

technical difficulties users have experienced, ODP is revising this deadline:

3⁄4 State homeland security strategies must now be submitted to ODP through the

Online DCT no later than January 31, 2004.

3⁄4 Submission of state homeland security strategies prior to the revised deadline will be

accepted by ODP. If necessary, these documents may be submitted in hard copy

and uploaded into the DCT. Hard copy submission should be coordinated with

your ODP Program Manager.

Please continue to utilize the ODP Technical Assistance Help Line for technical inquiries by

calling (877) 612-HELP (4357). Technicians are available to answer inquiries Monday through

Friday from 7 A.M. – 9 P.M. Central Standard Time (CST) and 10 A.M. – 6 P.M. CST on

Saturday and Sunday. Local users should continue to contact their State Administrator for

inquiries regarding assessment and/or strategy content. State Administrators should continue to

contact their ODP Program Manager for additional content information. General information

can be obtained by calling ODP’s Centralized Scheduling and Information Desk at (800) 368-

6498.

Thank you for your patience during this process. ODP will continue to update you on the status

of the DCT, and on any further developments regarding the assessment and strategy process.
<TABLE> <S> <C>

<ARTICLE>     5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
FROM THE BALANCE SHEET AND STATEMENT OF OPERATIONS AS OF AND FOR
THE THREE MONTHS ENDED MAY 3, 1997 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS AS INCLUDED IN THE COMPANY'S
QUARTERLY REPORT ON FORM 10-Q.

</LEGEND>
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JAN-31-1998
<PERIOD-END>                               MAY-03-1997
<CASH>                                           4,716
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                     38,513
<CURRENT-ASSETS>                                46,659
<PP&E>                                          11,944
<DEPRECIATION>                                   5,481
<TOTAL-ASSETS>                                  94,603
<CURRENT-LIABILITIES>                           34,409
<BONDS>                                              0
<COMMON>                                            17
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                         37 
<OTHER-SE>                                      18,531
<TOTAL-LIABILITY-AND-EQUITY>                    94,603
<SALES>                                         60,436
<TOTAL-REVENUES>                                60,436
<CGS>                                           39,313
<TOTAL-COSTS>                                   39,313
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,277
<INCOME-PRETAX>                                (1,360) 
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (1,360)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,360)
<EPS-PRIMARY>                                   (0.46)
<EPS-DILUTED>                                   (0.46)
        

</TABLE>
EXHIBIT 32
----------




                          CERTIFICATIONS OF
         CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
                 PURSUANT TO 18 U.S.C. SECTION 1350,
              AS ADOPTED PURSUANT TO SECTION 906 OF THE
                     SARBANES-OXLEY ACT OF 2002
         ---------------------------------------------------



     The following statement is provided by the undersigned to accompany
the Quarterly Report on Form 10-Q for the quarter ended September 30, 2009,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be
deemed filed pursuant to any provision of the Securities Exchange Act of
1934 or any other securities law:

     Each of the undersigned certifies that the foregoing Report on
Form 10-Q fully complies with the requirements of Section 13(a) of the
Securities Exchange Act of 1934 (15 U.S.C. 78m) and that the information
contained in the Form 10-Q fairly presents, in all material respects, the
financial condition and results of operations of ALP Liquidating Trust.




                                      /s/   Gary Nickele
                                      ------------------------------
                                      Gary Nickele
                                      Chief Executive Officer




                                      /s/   Gailen J. Hull
                                      ------------------------------
                                      Gailen J. Hull
                                      Chief Financial Officer and
                                      Principal Accounting Officer
<PAGE>

EXHIBIT 32 (b)

       CERTIFICATION PURSUANT TO 18 U.S.C SECTION 1350, AS ADOPTED PURSUANT
                TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Northland Cable Properties Seven
Limited Partnership (the "Partnership") on Form 10Q for the period ended June
30, 2006 as filed with the Securities and Exchange Commission on the date hereof
(the "Form 10-Q"), I, Gary Jones, President of Northland Communications
Corporation, the General Partner, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that;

      (1)   The Form 10-Q fully complies with the requirements of Section 13 (a)
            or (15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or
            78(d)); and

      (2)   The information contained in the Form 10-Q fairly presents in all
            material respects, the financial condition and results of operations
            of the Partnership.

DATE: 8-14-06

/s/  GARY S. JONES
     --------------------------------
     Gary S. Jones
     President

A signed original of this written statement required by Section 906 has been
provided to Northland Cable Properties Seven Limited Partnership and will be
retained by Northland Cable Properties Seven Limited Partnership and furnished
to the Securities and Exchange Commission or its staff upon request.
## COURT OF APPEALS

SECOND DISTRICT OF TEXAS

FORT WORTH

NO. 02

- 10

- 00309

- CV

KENNETH P. GROSS AND

BETSY L. GROSS APPELLANTS

V.

WB TEXAS RESORT

COMMUNITIES, L.P. APPELLEE

----------

FROM THE 141ST DISTRICT COURT OF TARRANT COUNTY

----------



### MEMORANDUM OPINION 1

----------

Twice we have abated this case on Appellants’ motions pending entry of a

final judgment or order from which they may appeal. In our most recent

abatement order

, we stated that if a supplemental clerk’s record containing a final

judgment wa s not filed by December 14, 2010 , then we could dismiss this case

for want of jurisdiction.

1 See Tex. R. App. P. 47.4.2

On December 14, 2010, Appellants notified us that they were unable to

secure a final order or judgment from the trial court by th at date and that

therefore they ha d no choice but to allow the appeal to be dismisse d without

prejudice . Accordingly, this appeal is dismissed for want of jurisdiction

. See Tex.

R. App. P. 42.3(a) , 43.2(f)

.

PER CURIAM

PANEL: GABRIEL, J

. ; LIVINGSTON, C.J.; and DAUPHINOT, J.

DELIVERED: January 2 7 , 2011
# C_2015346EN.01003801.xml

| 19.10.2015 | EN | Official Journal of the European Union | C 346/38 |
| --- | --- | --- | --- |

19.10.2015

EN

Official Journal of the European Union

C 346/38

---

Judgment of the Civil Service Tribunal (2nd Chamber) of 9 September 2015 — De Loecker v EEAS

(Case F-28/14) (1)

1

((Civil service - EEAS staff - Member of the temporary staff - Head of delegation in a third country - Breakdown in the relationship of trust - Transfer to the EEAS seat - Early termination of the employment contract - Period of notice - Reasons given for the decision - Article 26 of the Staff Regulations - Rights of the defence - Right to be heard))

(2015/C 346/42)

Language of the case: French

Parties

Parties

Applicant: Stéphane De Loecker (Brussels, Belgium) (represented by: initially, J.-N. Louis and D. Abreu de Caldas, lawyers, and subsequently J.-N. Louis and N. de Montigny, lawyers)

Applicant:

Defendant: European External Action Service (represented by: S. Marquardt and M. Silva, Agents)

Defendant:

Re:

Re:

Application for annulment of the decisions of the High Representative of the European Union to terminate the applicant’s contract as a member of the temporary staff, to refuse to hear him in respect of alleged psychological harassment, to reject his request for the appointment of an external investigator and to have his complaint registered as a request.

Operative part of the judgment

Operative part of the judgment

The Tribunal:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Declares that Mr De Loecker shall bear his own costs and orders him to pay all the costs incurred by the European External Action Service. |
| --- | --- |

2.

Declares that Mr De Loecker shall bear his own costs and orders him to pay all the costs incurred by the European External Action Service.

---

(1)  OJ C 184, 16.6.2014, p. 44.

1

---
<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000813897
<NAME> PSH MASTER L.P.I.
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               SEP-30-1998
<CASH>                                       1,039,733
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             1,039,733
<PP&E>                                           7,695
<DEPRECIATION>                                   7,504
<TOTAL-ASSETS>                               1,039,887
<CURRENT-LIABILITIES>                            1,090
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                   1,038,797
<TOTAL-LIABILITY-AND-EQUITY>                 1,039,887
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                   13,141
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                   (56)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                               (56)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      (56)
<EPS-PRIMARY>                                     0.00
<EPS-DILUTED>                                     0.00
        

</TABLE>
§ 524.802 Enrofloxacin and silver sulfadiazine otic emulsion. ( a ) *Specifications.* Each milliliter contains 5 milligrams (mg) enrofloxacin and 10 mg silver sulfadiazine.
( b ) *Sponsor.* See No. 058198 in § 510.600(c) of this chapter.
( c ) *Conditions of use* —*Dogs*— ( 1 ) *Amount.* 5 to 10 drops for dogs weighing 35 pounds (lb) or less and 10 to 15 drops for dogs weighing more than 35 lb; applied twice daily for up to 14 days.
( 2 ) *Indications for use.* For the treatment of otitis externa in dogs.
( 3 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian. Federal law prohibits the extralabel use of this drug in food-producing animals.
[65 FR 66620, Nov. 7, 2000, as amended at 79 FR 10967, Feb. 27, 2014; 86 FR 14821, Mar. 19, 2021]
§ 582.3280 Dilauryl thiodipropionate. ( a ) *Product.* Dilauryl thiodipropionate.
( b ) *Tolerance.* This substance is generally recognized as safe for use in food when the total content of antioxidants is not over 0.02 percent of fat or oil content, including essential (volatile) oil content of the food, provided the substance is used in accordance with good manufacturing or feeding practice.
§ 524.981e Fluocinolone and dimethyl sulfoxide otic solution. ( a ) *Specifications.* Each milliliter of solution contains 0.01 percent fluocinolone acetonide and 60 percent dimethyl sulfoxide.
( b ) *Sponsor.* See No. 054771 in § 510.600(c) of this chapter.
( c ) *Conditions of use in dogs* — ( 1 ) *Amount.* Instill 4 to 6 drops (0.2 milliliter) twice daily into the ear canal for a maximum period of 14 days. The total dosage used should not exceed 17 milliliters.
( 2 ) *Indications for use.* For the relief of pruritis and inflammation associated with acute and chronic otitis.
( 3 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[79 FR 10969, Feb. 27, 2014]
**Exhibit 32.1****CERTIFICATION**Each of the undersigned hereby certifies, in accordance with 18 U.S.C. 1350, as adopted pursuant toSection 906 of the Sarbanes-Oxley Act of 2002, in his capacity as an officer of Vitran CorporationInc., that, to his knowledge, the Annual Report of Vitran Corporation Inc. on Form 10-K for theyear ended December 31, 2007, fully complies with the requirements of Section 13(a) of theSecurities Exchange Act of 1934 and that the information contained in such report fairly presents,in all material respects, the financial condition and results of operation of Vitran CorporationInc.        Date: February 7, 2008 By:  /s/ RICHARD E. GAETZ    Richard E. Gaetz    President andChief Executive Officer       By:                                             /s/ SEAN P. WASHCHUK    Sean P. Washchuk    Vice President Finance andChief Financial Officer   
72
§ 582.3731 Sodium ascorbate. ( a ) *Product.* Sodium ascorbate.
( b ) *Conditions of use.* This substance is generally recognized as safe when used in accordance with good manufacturing or feeding practice.
This disposition is not appropriate for publication and is not precedent *

except as provided by 9th Cir. R. 36-3.

The panel unanimously concludes this case is suitable for decision **

without oral argument. See Fed. R. App. P. 34(a)(2).

NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

 FOR THE NINTH CIRCUIT

HEIDI AMAYA,

 Plaintiff - Appellant,

 v.

JASON JOHN VAN BEEK; et al.,

 Defendants - Appellees.

No. 10-55538

D.C. No. 8:09-cv-00749-CJC-SS

MEMORANDUM*

Appeal from the United States District Court

for the Central District of California

Cormac J. Carney, District Judge, Presiding

Submitted March 12, 2013** 

Before: PREGERSON, REINHARDT, and W. FLETCHER, Circuit Judges. 

Heidi Amaya appeals pro se from the district court’s order remanding her

action to the California state courts after declining to exercise supplemental

jurisdiction over her second amended complaint under 28 U.S.C. § 1367. We have

FILED

MAR 21 2013

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS
2 10-55538

jurisdiction under 28 U.S.C. § 1291. We review for an abuse of discretion a

district court’s decision to decline supplemental jurisdiction. Wash. State

Republican Party v. Wash. State Grange, 676 F.3d 784, 797 (9th Cir. 2012). We

have a special obligation to satisfy ourselves of the district court’s subject matter

jurisdiction. Steel Co. v. Citizens for a Better Env’t, 523 U.S. 83, 95 (1998). We

vacate and remand.

Remand of Amaya’s action to state court was required because Amaya’s

original complaint provided no basis for federal subject matter jurisdiction, making

removal improper. See 28 U.S.C. § 1441(a); see also Sparta Surgical Corp. v.

Nat’l Ass’n of Sec. Dealers, Inc., 159 F.3d 1209, 1213 (9th Cir. 1998)

(“[J]urisdiction must be analyzed on the basis of the pleadings filed at the time of

removal without reference to subsequent amendments.”); Rains v. Criterion Sys.,

Inc., 80 F.3d 339, 346 (9th Cir. 1996) (“When a claim can be supported by

alternative and independent theories—one of which is a state law theory and one of

which is a federal law theory—federal question jurisdiction does not attach

because federal law is not a necessary element of the claim.”). Accordingly, we

vacate and remand with instructions for the district court to vacate its prior orders,

and to remand the action to state court.
3 10-55538

The parties shall bear their own costs on appeal.

VACATED and REMANDED.
• Family Forest Alliance ◦ Resources ◦ Alliance Materials ◦ Headlines • SmartLogging • Certification Services • FSC Group Certifications ◦ Forest Management Group ◾ Management Group Member Resources ◾ FSC Label Use Procedures ◦ Chain of Custody Group ◾ Custody Group Member Resources ◾ FSC Label Use Procedures ◦ Useful Links • About Us 

# About Us The Trust to Conserve Northeast Forestlands (TCNF)is a 501(c)3 organization formed by the Professional Logging Contractors of Maine in 2003to administer the Northeast Master Logger Certification program with the broader goal of "enhancing the health of the working forest through exceptional accountability" throughout the Northern Forest region. In addition to overseeing the Master Logger Program, TCNF serves as an administrator for a group Forest Stewardship Council TM (FSC ® ) Chain of Custody certification (RA-COC-001677) and an FSC-certified group of family forest landowners (RA-FM/COC-001881). Under this group arrangement, natural resource professionals can inexpensively gain access to FSC certification for their landowner clients. In support of these certification programs, TCNF is working to develop market-based incentives to practice sustainable and ecologically responsible forest management. The Trust also provides services for companies seeking individual chain of custody or controlled wood certification. We prepare chain of custody systems and documentation, develop controlled wood risk assessments, provide staff training, and prepare the company for audits and assessments. The Trust’s public statement on responsible wood sourcing. 

### Page 1 of 2 TrusttoConserveNortheastForestlands - AboutUs

6/23/2016 http://tcnef.brownrice.com/index.php?page=about - us

### Page 2 of 2

TrusttoConserveNortheastForestlands - AboutUs

6/23/2016 http://tcnef.brownrice.com/index.php?page=about - us
§ 520.447 Clindamycin solution. ( a ) *Specifications.* Each milliliter of solution contains the equivalent of 25 milligrams (mg) clindamycin as the hydrochloride salt.
( b ) *Sponsors.* See Nos. 051311, 054771, 058829, 061133, and 069043 in § 510.600(c) of this chapter.
( c ) *Special considerations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
( d ) *Conditions of use* — ( 1 ) *Dogs* — ( i ) *Amount.* Wounds, abscesses, and dental infections: 2.5 to 15 mg per pound (/lb) body weight every 12 hours for a maximum of 28 days. Osteomyelitis: 5.0 to 15 mg/lb body weight every 12 hours for a minimum of 28 days.
( ii ) *Indications for use.* For the treatment of skin infections (wounds and abscesses) due to susceptible strains of coagulase-positive staphylococci (*Staphylococcus aureus* or *S. intermedius*), deep wounds and abscesses due to susceptible strains of *Bacteroides fragilis*, *Prevotella melaninogenicus*, *Fusobacterium necrophorum*, and *Clostridium perfringens*; dental infections due to susceptible strains of *S. aureus*, *B. fragilis*, *P. melaninogenicus*, *F. necrophorum*, and *C. perfringens*; and osteomyelitis due to susceptible strains of *S. aureus*, *B. fragilis*, *P. melaninogenicus*, *F. necrophorum*, and *C. perfringens.*
( 2 ) Cats— ( i ) *Amount.* 5.0 to 15.0 mg/lb body weight every 24 hours for a maximum of 14 days.
( ii ) *Indications for use.* For the treatment of skin infections (wounds and abscesses) due to susceptible strains of *Staphylococcus aureus*, *S. intermedius*, *Streptococcus spp.*; deep wounds and abscesses due to susceptible strains of *Clostridium perfringens* and *Bacteroides fragilis*; and dental infections due to susceptible strains of *S. aureus*, *S. intermedius*, *Streptococcus spp.*, *C. perfringens*, and *B. fragilis.*
[67 FR 54954, Aug. 27, 2002, as amended at 67 FR 78684, Dec. 26, 2002; 68 FR 55824, Sept. 29, 2003; 69 FR 31734, June 7, 2004; 71 FR 39543, July 13, 2006; 72 FR 19796, Apr. 20, 2007; 78 FR 17596, Mar. 22, 2013; 78 FR 30197, May 22, 2013; 79 FR 28819, May 20, 2014; 81 FR 17607, Mar. 30, 2016; 84 FR 8972, Mar. 13, 2019]